Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2023-04-17 Sale | 2023-04-19 6:00 pm | Intra-Cellular Therapies Inc. | ITCI | VAN NOSTRAND ROBERT L Director | 10,000 | $63 | $630,000 | 9,345 (Direct) | View |
| 2023-03-28 Sale | 2023-03-30 5:08 pm | Intra-Cellular Therapies Inc. | ITCI | Neumann Mark EVP, Chief Commercial Officer | 15,604 | $54.31 | $847,380 | 45,339 (Direct) | View |
| 2023-03-13 Sale | 2023-03-13 7:36 pm | Intra-Cellular Therapies Inc. | ITCI | Durgam Suresh K. EVP, Chief Medical Officer | 7,344 | $45.04 | $330,794 | 37,794 (Direct) | View |
| 2023-03-10 Sale | 2023-03-13 7:35 pm | Intra-Cellular Therapies Inc. | ITCI | Neumann Mark EVP, Chief Commercial Officer | 12,308 | $43.84 | $539,599 | 75,633 (Direct) | View |
| 2023-03-10 Sale | 2023-03-13 7:34 pm | Intra-Cellular Therapies Inc. | ITCI | Halstead Michael EVP and General Counsel | 24,052 | $43.66 | $1,050,092 | 14,690 (Direct) | View |
| 2023-03-10 Sale | 2023-03-13 7:32 pm | Intra-Cellular Therapies Inc. | ITCI | Hineline Lawrence J. SVP of Finance CFO | 21,245 | $43.55 | $925,225 | 11,164 (Direct) | View |
| 2023-03-10 Sale | 2023-03-13 7:31 pm | Intra-Cellular Therapies Inc. | ITCI | Mates Sharon Chairman, President & CEO | 62,335 | $43.76 | $2,727,841 | 1,191,440 (Direct) | View |
| 2023-03-01 Sale | 2023-03-03 7:03 pm | Intra-Cellular Therapies Inc. | ITCI | Neumann Mark EVP, Chief Commercial Officer | 7,241 | $50.01 | $362,122 | 49,199 (Direct) | View |
| 2023-02-24 Sale | 2023-02-27 8:03 pm | Intra-Cellular Therapies Inc. | ITCI | Neumann Mark EVP, Chief Commercial Officer | 4,046 | $47.12 | $190,648 | 64,347 (Direct) | View |
| 2023-02-24 Sale | 2023-02-27 8:02 pm | Intra-Cellular Therapies Inc. | ITCI | Durgam Suresh K. SVP, Chief Medical Officer | 7,906 | $47.14 | $372,689 | 31,011 (Direct) | View |
| 2023-02-24 Sale | 2023-02-27 8:01 pm | Intra-Cellular Therapies Inc. | ITCI | Halstead Michael EVP and General Counsel | 7,906 | $47.03 | $371,819 | 7,907 (Direct) | View |
| 2023-02-24 Sale | 2023-02-27 8:00 pm | Intra-Cellular Therapies Inc. | ITCI | Hineline Lawrence J. SVP of Finance CFO | 7,455 | $47.03 | $350,609 | 7,455 (Direct) | View |
| 2023-02-24 Sale | 2023-02-27 7:59 pm | Intra-Cellular Therapies Inc. | ITCI | Mates Sharon Chairman, President & CEO | 22,590 | $47.03 | $1,062,408 | 1,172,899 (Direct) | View |
| 2023-02-21 Sale | 2023-02-22 8:05 pm | Intra-Cellular Therapies Inc. | ITCI | Neumann Mark EVP, Chief Commercial Officer | 3,898 | $47.01 | $183,246 | 52,580 (Direct) | View |
| 2023-02-21 Sale | 2023-02-22 8:04 pm | Intra-Cellular Therapies Inc. | ITCI | Durgam Suresh K. SVP, Chief Medical Officer | 8,354 | $46.84 | $391,304 | 23,104 (Direct) | View |
| 2023-02-21 Sale | 2023-02-22 8:03 pm | Intra-Cellular Therapies Inc. | ITCI | Halstead Michael EVP and General Counsel | 11,139 | $46.84 | $521,699 | 0 (Direct) | View |
| 2023-02-17 Sale | 2023-02-22 8:02 pm | Intra-Cellular Therapies Inc. | ITCI | Hineline Lawrence J. SVP of Finance CFO | 64,411 | $49.34 | $3,178,354 | 0 (Direct) | View |
| 2023-02-21 Sale | 2023-02-22 8:01 pm | Intra-Cellular Therapies Inc. | ITCI | Mates Sharon Chairman, President & CEO | 27,848 | $46.83 | $1,304,000 | 1,100,309 (Direct) | View |
| 2022-12-19 Sale | 2022-12-21 4:06 pm | Intra-Cellular Therapies Inc. | ITCI | MARCUS JOEL S Director | 5,000 | $50.82 | $254,100 | 39,233 (Indirect Direct) | View |
| 2022-12-13 Sale | 2022-12-15 7:01 pm | Intra-Cellular Therapies Inc. | ITCI | Mates Sharon Chairman, President & CEO | 33,083 | $55 | $1,819,565 | 1,100,309 (Direct) | View |
| 2022-12-01 Sale | 2022-12-02 7:14 pm | Intra-Cellular Therapies Inc. | ITCI | Halstead Michael EVP and General Counsel | 50,000 | $53.73 | $2,686,514 | 15,164 (Direct) | View |
| 2022-11-07 Sale | 2022-11-08 4:12 pm | Intra-Cellular Therapies Inc. | ITCI | MARCUS JOEL S Director | 10,000 | $52.3 | $523,023 | 44,233 (Indirect Direct) | View |
| 2022-09-21 Sale | 2022-09-23 9:01 pm | Intra-Cellular Therapies Inc. | ITCI | Hineline Lawrence J. SVP of Finance CFO | 65,164 | $45.63 | $2,973,406 | 0 (Direct) | View |
| 2022-08-11 Sale | 2022-08-12 6:09 pm | Intra-Cellular Therapies Inc. | ITCI | VAN NOSTRAND ROBERT L Director | 30,000 | $57.13 | $1,713,975 | 19,043 (Direct) | View |
| 2022-08-11 Sale | 2022-08-12 6:05 pm | Intra-Cellular Therapies Inc. | ITCI | MARCUS JOEL S Director | 10,000 | $59.22 | $592,200 | 54,233 (Indirect Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2023-04-17 Exercise | 2023-04-19 6:00 pm | N/A 2029-06-24 | Intra-Cellular Therapies Inc. | ITCI | VAN NOSTRAND ROBERT L Director | 10,000 | $0 | 9,345 (Direct) | View |
| 2023-04-17 Exercise | 2023-04-19 6:00 pm | N/A N/A | Intra-Cellular Therapies Inc. | ITCI | VAN NOSTRAND ROBERT L Director | 10,000 | $13.05 | 9,345 (Direct) | View |
| 2023-03-31 Option Award | 2023-04-04 5:03 pm | N/A N/A | Intra-Cellular Therapies Inc. | ITCI | VAN NOSTRAND ROBERT L Director | 95 | $54.15 | 9,345 (Direct) | View |
| 2023-03-31 Option Award | 2023-04-04 5:01 pm | N/A N/A | Intra-Cellular Therapies Inc. | ITCI | RIGGS RORY B Director | 313 | $54.15 | 78,360 (Direct) | View |
| 2023-03-10 Exercise | 2023-03-13 7:36 pm | N/A N/A | Intra-Cellular Therapies Inc. | ITCI | Durgam Suresh K. EVP, Chief Medical Officer | 7,344 | $0 | 37,794 (Direct) | View |
| 2023-03-10 Exercise | 2023-03-13 7:35 pm | N/A N/A | Intra-Cellular Therapies Inc. | ITCI | Neumann Mark EVP, Chief Commercial Officer | 7,344 | $0 | 75,633 (Direct) | View |
| 2023-03-09 Option Award | 2023-03-13 7:35 pm | N/A N/A | Intra-Cellular Therapies Inc. | ITCI | Neumann Mark EVP, Chief Commercial Officer | 16,708 | $0 | 75,633 (Direct) | View |
| 2023-03-10 Exercise | 2023-03-13 7:34 pm | N/A N/A | Intra-Cellular Therapies Inc. | ITCI | Halstead Michael EVP and General Counsel | 7,344 | $0 | 14,690 (Direct) | View |
| 2023-03-09 Option Award | 2023-03-13 7:34 pm | N/A N/A | Intra-Cellular Therapies Inc. | ITCI | Halstead Michael EVP and General Counsel | 16,708 | $0 | 14,690 (Direct) | View |
| 2023-03-10 Exercise | 2023-03-13 7:32 pm | N/A N/A | Intra-Cellular Therapies Inc. | ITCI | Hineline Lawrence J. SVP of Finance CFO | 5,582 | $0 | 11,164 (Direct) | View |
| 2023-03-09 Option Award | 2023-03-13 7:32 pm | N/A N/A | Intra-Cellular Therapies Inc. | ITCI | Hineline Lawrence J. SVP of Finance CFO | 15,663 | $0 | 11,164 (Direct) | View |
| 2023-03-10 Exercise | 2023-03-13 7:31 pm | N/A N/A | Intra-Cellular Therapies Inc. | ITCI | Mates Sharon Chairman, President & CEO | 40,565 | $0 | 1,191,440 (Direct) | View |
| 2023-03-13 Exercise | 2023-03-13 7:31 pm | N/A N/A | Intra-Cellular Therapies Inc. | ITCI | Mates Sharon Chairman, President & CEO | 20,000 | $3.26 | 1,191,440 (Direct) | View |
| 2023-03-09 Option Award | 2023-03-13 7:31 pm | N/A N/A | Intra-Cellular Therapies Inc. | ITCI | Mates Sharon Chairman, President & CEO | 41,770 | $0 | 1,191,440 (Direct) | View |
| 2023-03-06 Option Award | 2023-03-08 7:54 pm | N/A N/A | Intra-Cellular Therapies Inc. | ITCI | Durgam Suresh K. EVP, Chief Medical Officer | 39,398 | $0 | 39,398 (Direct) | View |
| 2023-03-06 Option Award | 2023-03-08 7:52 pm | N/A N/A | Intra-Cellular Therapies Inc. | ITCI | Neumann Mark EVP, Chief Commercial Officer | 39,398 | $0 | 39,398 (Direct) | View |
| 2023-03-06 Option Award | 2023-03-08 7:51 pm | N/A N/A | Intra-Cellular Therapies Inc. | ITCI | Halstead Michael EVP and General Counsel | 39,398 | $0 | 39,398 (Direct) | View |
| 2023-03-06 Option Award | 2023-03-08 7:50 pm | N/A N/A | Intra-Cellular Therapies Inc. | ITCI | Hineline Lawrence J. SVP of Finance CFO | 39,398 | $0 | 39,398 (Direct) | View |
| 2023-03-06 Option Award | 2023-03-08 7:49 pm | N/A N/A | Intra-Cellular Therapies Inc. | ITCI | Mates Sharon Chairman, President & CEO | 122,137 | $0 | 122,137 (Direct) | View |
| 2023-02-23 Exercise | 2023-02-27 8:03 pm | N/A N/A | Intra-Cellular Therapies Inc. | ITCI | Neumann Mark EVP, Chief Commercial Officer | 7,906 | $0 | 64,347 (Direct) | View |
| 2023-02-23 Exercise | 2023-02-27 8:02 pm | N/A N/A | Intra-Cellular Therapies Inc. | ITCI | Durgam Suresh K. SVP, Chief Medical Officer | 7,906 | $0 | 31,011 (Direct) | View |
| 2023-02-23 Exercise | 2023-02-27 8:01 pm | N/A N/A | Intra-Cellular Therapies Inc. | ITCI | Halstead Michael EVP and General Counsel | 7,906 | $0 | 7,907 (Direct) | View |
| 2023-02-23 Exercise | 2023-02-27 8:00 pm | N/A N/A | Intra-Cellular Therapies Inc. | ITCI | Hineline Lawrence J. SVP of Finance CFO | 7,455 | $0 | 7,455 (Direct) | View |
| 2023-02-23 Exercise | 2023-02-27 7:59 pm | N/A N/A | Intra-Cellular Therapies Inc. | ITCI | Mates Sharon Chairman, President & CEO | 52,590 | $0 | 1,172,899 (Direct) | View |
| 2023-02-24 Exercise | 2023-02-27 7:59 pm | N/A N/A | Intra-Cellular Therapies Inc. | ITCI | Mates Sharon Chairman, President & CEO | 30,000 | $3.26 | 1,172,899 (Direct) | View |
| 2023-02-18 Exercise | 2023-02-22 8:05 pm | N/A N/A | Intra-Cellular Therapies Inc. | ITCI | Neumann Mark EVP, Chief Commercial Officer | 11,139 | $0 | 52,580 (Direct) | View |
| 2023-02-18 Exercise | 2023-02-22 8:04 pm | N/A N/A | Intra-Cellular Therapies Inc. | ITCI | Durgam Suresh K. SVP, Chief Medical Officer | 8,354 | $0 | 23,104 (Direct) | View |
| 2023-02-18 Exercise | 2023-02-22 8:03 pm | N/A N/A | Intra-Cellular Therapies Inc. | ITCI | Halstead Michael EVP and General Counsel | 11,139 | $0 | 0 (Direct) | View |
| 2023-02-17 Exercise | 2023-02-22 8:02 pm | N/A N/A | Intra-Cellular Therapies Inc. | ITCI | Hineline Lawrence J. SVP of Finance CFO | 53,968 | $12.73 | 0 (Direct) | View |
| 2023-02-17 Exercise | 2023-02-22 8:02 pm | N/A 2029-01-07 | Intra-Cellular Therapies Inc. | ITCI | Hineline Lawrence J. SVP of Finance CFO | 64,411 | $0 | 0 (Direct) | View |
| 2023-02-18 Exercise | 2023-02-22 8:01 pm | N/A N/A | Intra-Cellular Therapies Inc. | ITCI | Mates Sharon Chairman, President & CEO | 27,848 | $0 | 1,100,309 (Direct) | View |
| 2022-12-30 Option Award | 2023-01-03 4:19 pm | N/A N/A | Intra-Cellular Therapies Inc. | ITCI | VAN NOSTRAND ROBERT L Director | 97 | $52.92 | 9,250 (Direct) | View |
| 2022-12-30 Option Award | 2023-01-03 4:18 pm | N/A N/A | Intra-Cellular Therapies Inc. | ITCI | RIGGS RORY B Director | 321 | $52.92 | 78,047 (Direct) | View |
| 2022-12-01 Exercise | 2022-12-02 7:14 pm | N/A 2028-01-03 | Intra-Cellular Therapies Inc. | ITCI | Halstead Michael EVP and General Counsel | 50,000 | $0 | 15,164 (Direct) | View |
| 2022-12-01 Exercise | 2022-12-02 7:14 pm | N/A N/A | Intra-Cellular Therapies Inc. | ITCI | Halstead Michael EVP and General Counsel | 50,000 | $15.47 | 15,164 (Direct) | View |
| 2022-09-30 Option Award | 2022-10-05 4:04 pm | N/A N/A | Intra-Cellular Therapies Inc. | ITCI | VAN NOSTRAND ROBERT L Director | 110 | $46.53 | 9,153 (Direct) | View |
| 2022-09-30 Option Award | 2022-10-04 4:11 pm | N/A N/A | Intra-Cellular Therapies Inc. | ITCI | RIGGS RORY B Director | 365 | $46.53 | 77,726 (Direct) | View |
| 2022-09-21 Exercise | 2022-09-23 9:01 pm | N/A 2028-01-03 | Intra-Cellular Therapies Inc. | ITCI | Hineline Lawrence J. SVP of Finance CFO | 65,164 | $0 | 0 (Direct) | View |
| 2022-09-21 Exercise | 2022-09-23 9:01 pm | N/A N/A | Intra-Cellular Therapies Inc. | ITCI | Hineline Lawrence J. SVP of Finance CFO | 65,164 | $15.47 | 0 (Direct) | View |
| 2022-08-11 Exercise | 2022-08-12 6:09 pm | N/A 2027-06-27 | Intra-Cellular Therapies Inc. | ITCI | VAN NOSTRAND ROBERT L Director | 30,000 | $0 | 19,043 (Direct) | View |
| 2022-08-11 Exercise | 2022-08-12 6:09 pm | N/A N/A | Intra-Cellular Therapies Inc. | ITCI | VAN NOSTRAND ROBERT L Director | 20,000 | $12.45 | 19,043 (Direct) | View |
| 2022-08-11 Exercise | 2022-08-12 6:09 pm | N/A N/A | Intra-Cellular Therapies Inc. | ITCI | VAN NOSTRAND ROBERT L Director | 10,000 | $13.05 | 19,043 (Direct) | View |
| 2022-06-30 Option Award | 2022-07-05 4:08 pm | N/A N/A | Intra-Cellular Therapies Inc. | ITCI | VAN NOSTRAND ROBERT L Director | 108 | $57.08 | 9,043 (Direct) | View |
| 2022-06-30 Option Award | 2022-07-05 4:06 pm | N/A N/A | Intra-Cellular Therapies Inc. | ITCI | RIGGS RORY B Director | 289 | $57.08 | 77,361 (Direct) | View |
| 2022-06-09 Option Award | 2022-06-13 5:11 pm | 2023-06-09 2032-06-08 | Intra-Cellular Therapies Inc. | ITCI | MARCUS JOEL S Director | 16,757 | $0 | 16,757 (Direct) | View |
| 2022-06-09 Option Award | 2022-06-13 5:08 pm | 2023-06-09 2032-06-08 | Intra-Cellular Therapies Inc. | ITCI | RIGGS RORY B Director | 16,757 | $0 | 16,757 (Direct) | View |